Histogen is a regenerative medicine company focused on developing patented, innovative technologies for aesthetic and therapeutic markets based on stimulating the body’s stem cells to regenerate tissues and restore youthful function. The Company’s lead therapeutic product has demonstrated in clinical studies to stimulate hair growth, addressing an underserved, multibillion dollar global market. Further applications of the technology include skincare, orthopedics indications such as cartilage formation and spinal disk repair, wound healing and dermal fillers.
History
Histogen, Inc., a Delaware Corporation, was founded in 2007 to develop innovative products utilizing the proteins and growth factors produced by cells grown under simulated embryonic conditions. The Company is headquartered in San Diego, California.
Histogen founder Dr. Gail Naughton is a highly respected scientist with extensive experience in the field of tissue engineering and regenerative medicine. Dr. Naughton discovered the potential of proteins and growth factors produced by hypoxia-induced multipotent cells for therapeutic and biomedical applications, and developed Histogen’s unique technology process to create products based on these proteins. The technology is protected by patent families filed in the US and across key geographies.
